Brinson Patrick Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Brinson Patrick. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Brinson Patrick.

Country All Countries

• United States(NYSE & NASDAQ)
• United States(All Exchanges)
• Canada
• United Kingdom

Sector All Sectors

• Aerospace
• Auto/Tires/Trucks
• Basic Materials
• Business Services
• Computer and Technology
• Construction
• Consumer Discretionary
• Consumer Goods
• Consumer Staples
• Finance
• Industrial Products
• Medical
• Miscellaneous
• Multi-Sector Conglomerates
• Oils/Energy
• Retail/Wholesale
• Services
• Transportation
• Utilities

All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription

MarketRank™Upgrade to All Access to use the All Ranks Filter

Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription

Media SentimentUpgrade to All Access to use the All Sentiments Filter

Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription

Analyst ConsensusUpgrade to All Access to use the All Ratings Filter

Export to Excel

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details	Actions
LGND Ligand Pharmaceuticals	$107.14 +1.1%	3/25/2014	Target Set by	Brinson Patrick	-		$98.00	N/A	View details for Brinson Patrick rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 3/25/2014
MBOT Microbot Medical	$1.04 +5.1%	7/2/2014	Initiated by	Brinson Patrick	-	Outperform	$84.00	N/A	View details for Brinson Patrick rating of Microbot Medical (NASDAQ:MBOT) on 7/2/2014
MNKD MannKind	$5.85 +0.9%	6/30/2014	Target Raised by	Brinson Patrick	-	Outperform	$12.00 -> $15.00	N/A	View details for Brinson Patrick rating of MannKind (NASDAQ:MNKD) on 6/30/2014
RGLS Regulus Therapeutics	$1.78 +1.1%	5/13/2014	Initiated by	Brinson Patrick	-	Outperform		N/A	View details for Brinson Patrick rating of Regulus Therapeutics (NASDAQ:RGLS) on 5/13/2014
BCRX BioCryst Pharmaceuticals	$7.85 +4.0%	4/14/2014	Initiated by	Brinson Patrick	-	Outperform	$15.00	N/A	View details for Brinson Patrick rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 4/14/2014
MNKD MannKind	$5.85 +0.9%	4/8/2014	Initiated by	Brinson Patrick	-	Outperform	$12.00	N/A	View details for Brinson Patrick rating of MannKind (NASDAQ:MNKD) on 4/8/2014
CORT Corcept Therapeutics	$35.60 +2.1%	4/1/2014	Initiated by	Brinson Patrick	-	Outperform	$8.00	N/A	View details for Brinson Patrick rating of Corcept Therapeutics (NASDAQ:CORT) on 4/1/2014
LGND Ligand Pharmaceuticals	$107.14 +1.1%	3/24/2014	Initiated by	Brinson Patrick	-	Outperform		N/A	View details for Brinson Patrick rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 3/24/2014
MNKD MannKind	$5.85 +0.9%	6/21/2013	Initiated by	Brinson Patrick	-	Outperform		N/A	View details for Brinson Patrick rating of MannKind (NASDAQ:MNKD) on 6/21/2013
NVAX Novavax	$17.11 +2.6%	3/11/2013	Reiterated by	Brinson Patrick	-	Outperform		N/A	View details for Brinson Patrick rating of Novavax (NASDAQ:NVAX) on 3/11/2013
MNKD MannKind	$5.85 +0.9%	12/3/2012	Initiated by	Brinson Patrick	-	Outperform	$6.00	N/A	View details for Brinson Patrick rating of MannKind (NASDAQ:MNKD) on 12/3/2012
NVAX Novavax	$17.11 +2.6%	10/29/2012	Initiated by	Brinson Patrick	-	Outperform	$60.00	N/A	View details for Brinson Patrick rating of Novavax (NASDAQ:NVAX) on 10/29/2012

MarketBeat Community Rating for Brinson Patrick

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.